Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs.
Kevin DuncanFrank X ScheuermeyerDaniel LaneKeith AhamadJessica MoeKathryn DongSeonaid NolanJane BuxtonIsabelle MilesCheyenne JohnsonJim ChristensonMadelyn WhyteRaoul DaoustEmma GarrodKatherin BadkeAndrew KestlerPublished in: CJEM (2023)
Although less than half of our study population accepted buprenorphine/naloxone to-go when offered, most thought this intervention was beneficial. In isolation, ED buprenorphine/naloxone to-go will not meet the needs of all patients with opioid use disorder. Clinicians and policy makers should consider buprenorphine/naloxone to-go as a low-barrier option for opioid use disorder treatment from the ED when integrated with robust addiction care services.